These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8644191)

  • 1. Regional vs national renal sharing organizations: pros and cons.
    Bertoni E; Carmellini M; Tosi P; Bandini S; Nicita G; Taddei G; Pradella F; Fossombroni V; Rosati A; Zanazzi M; Rindi P; Rizzo G; Mattiuz P; Mosca F; Salvadori M
    Transplant Proc; 1996 Feb; 28(1):226-7. PubMed ID: 8644191
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional vs. national renal sharing organizations: pros and cons.
    Bertoni E; Carmellini M; Bandini S; Tosi P; Zanazzi M; Rosati A; Pradella F; Fossombroni V; Rindi P; Rizzo G; Mattiuz P; Mosca F; Salvadori M
    Clin Transplant; 1997 Jun; 11(3):214-6. PubMed ID: 9193845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
    Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
    Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
    [No Abstract]   [Full Text] [Related]  

  • 4. Organ sharing based on HLA matching saves dialysis years and patient lives.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1993 Dec; 25(6):3049-50. PubMed ID: 8266448
    [No Abstract]   [Full Text] [Related]  

  • 5. Kidney transplant policy on HLA matching and waiting list.
    Adorno D; Papola F; Valeri M; Piazza A; Torlone N; Monaco PI; Provenzani L; Celeste MG; Casciani CU
    Transplant Proc; 1991 Oct; 23(5):2680. PubMed ID: 1926534
    [No Abstract]   [Full Text] [Related]  

  • 6. Omit HLA matching to attain shorter cold ischemic time?
    Aswad S; Mann SL; Khetan U; Asai P; Bogaard T; Mendez RG; Mendez R
    Transplant Proc; 1993 Dec; 25(6):3053-5. PubMed ID: 8266450
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
    Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
    Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal transplant graft survival results and HLA-A,B, DR mismatching.
    Cicciarelli J; Iwaki Y; McCalmon R; Thompson J
    Transplant Proc; 1995 Feb; 27(1):660-3. PubMed ID: 7879135
    [No Abstract]   [Full Text] [Related]  

  • 10. The feasibility of HLA matching for lung transplantation.
    McGee C; Fox MD; Loyd JE
    Clin Transplant; 1996 Dec; 10(6 Pt 1):564-7. PubMed ID: 8996780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA compatibility can be predicted by matching only three residues with outward oriented sidechains.
    Takemoto S; Terasaki PI
    Transplant Proc; 1996 Jun; 28(3):1264-6. PubMed ID: 8658652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA analysis of kidney transplants performed in member countries of MESOT. Middle East Society for Organ Transplantation.
    Opelz G
    Transplant Proc; 1997 Nov; 29(7):2917-9. PubMed ID: 9365613
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing the priority for HLA matching in kidney transplantation.
    Kamoun M; Sellers MT
    N Engl J Med; 2004 May; 350(20):2095-6; author reply 2095-6. PubMed ID: 15146574
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional kidney allocation based only on full HLA-DR compatibility is not feasible.
    Heemskerk MB; Haase-Kromwijk BJ; Claas FH; Doxiadis II; Haasnoot GW; Homan van der Heide JJ; Weimar WW; Hoitsma AJ
    Transplantation; 2009 Aug; 88(4):600-1. PubMed ID: 19696649
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-DR mismatching in cadaveric kidney transplantation minimized through organ sharing for 1000 consecutive transplants.
    Martin S; Connolly J; Parrott NR; Pearson RC; Johnson RW; Dyer PA
    Transplant Proc; 1993 Dec; 25(6):3047-8. PubMed ID: 8266447
    [No Abstract]   [Full Text] [Related]  

  • 16. A retrospective evaluation of HLA-A,B, and genomic HLA-DR compatibility in orthotopic liver transplantation.
    Poli F; Nocco A; Crespiatico L; Cattaneo R; Lecchi L; Scalamogna M; Sirchia G
    Transplant Proc; 1994 Dec; 26(6):3614-5. PubMed ID: 7998293
    [No Abstract]   [Full Text] [Related]  

  • 17. Changing the priority for HLA matching in kidney transplantation.
    Spital A; Wendt KJ
    N Engl J Med; 2004 May; 350(20):2095-6; author reply 2095-6. PubMed ID: 15146573
    [No Abstract]   [Full Text] [Related]  

  • 18. ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney.
    Bryan CF; Cherikh WS; Cheng Y; Aeder MI; Muruve NA; Nelson PW; Shield CF; Warady BA; Winklhofer FT
    Clin Transplant; 2004; 18 Suppl 12():55-60. PubMed ID: 15217409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation: a global perspective.
    Shrestha BM
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):267-8. PubMed ID: 18603914
    [No Abstract]   [Full Text] [Related]  

  • 20. Cadaver kidney transplantation in the north Italy transplant program in the nineties.
    Sirchia G; Mascaretti L; Poli F; Scalamogna M; Pappalettera M; Pizzi C
    Clin Transpl; 1995; ():241-54. PubMed ID: 8794270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.